Science
Mechanism of Action
This botanical extract operates on the skin by significantly reducing inflammatory markers, particularly those induced by UVB radiation. Its mechanism involves upregulating the anti-inflammatory enzyme heme oxygenase-1, concurrently decreasing the expression of matrix metalloproteinases (MMP)-3 and -9. Furthermore, it inhibits the MAPK signaling pathway, leading to a reduction in reactive oxygen species (ROS) and mitigating UVB-induced phosphorylation of ERK and JNK, thereby helping to repair skin damage and reduce free radical effects.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 In UVB-induced human skin keratinocytes, Syzygium formosum leafy extract significantly reduced markers of skin inflammation. It also induced the anti-inflammatory enzyme heme oxygenase-1, decreased MMP-3 and -9 expression, inhibited the MAPK pathway, and diminished UVB-induced reactive oxygen species (ROS).
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
Formal safety reviews or GHS classifications for Eugenia operculata leaf powder are currently unavailable, suggesting a need for further safety assessment in cosmetic applications.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Eugenia Operculata Leaf Powder presents as a valuable ingredient with promising anti-inflammatory and antioxidant properties based on compelling in vitro data, though further in vivo studies and comprehensive safety assessments are recommended for optimal formulation.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources